Ozempic Price Cut; Hypoparathyroidism Tx Fast Tracked; Halle Berry's Menopause Bill News and commentary from the endocrinology world May 07, 2024
Some Patients Suffered Psychiatric Issues After Ozempic Initiation Two case reports detailed suicidal ideation, mania in weeks following semaglutide initiation May 05, 2024
FTC Challenges 'Bogus' Patents on Ozempic and Other Drugs Patents block competition and inflate prescription drug cost, says FTC chair May 01, 2024
Hypothalamic Obesity Tx; Weekly Insulin Under Review; Ozempic Price Investigation News and commentary from the endocrinology world Apr 30, 2024
Patients Hitting GLP-1 Plateaus? Here's How to Help Set expectations up front, and explore alternative approaches when necessary Apr 30, 2024
What Do Weight-Loss Drugs Mean for Diet Industry Built on Eating Less and Exercise? Gym and diet food companies look to muscle in Apr 25, 2024
New T2D Guidelines; More Cushing's Relacorilant Data; Drug Shortages Rage On News and commentary from the endocrinology world Apr 23, 2024
Ozempic Hiatus Before Surgery: Is a Weeklong Pause Really Needed? Incidence of respiratory complications similar to other antidiabetic agents, claims data suggest Apr 22, 2024
Underweight, but Not Obesity, Linked to Glaucoma Progression Meanwhile, tobacco/alcohol use had no significant links to changes in retinal nerve fiber layer Apr 22, 2024
Time-Restricted Eating Tied to Modest Weight Loss Benefits appeared to come mainly from reduced caloric intake Apr 19, 2024
Tirzepatide Improves Sleep Apnea in Patients With Obesity, Drugmaker Says Topline results add yet another potential reason for use of dual GIP/GLP-1 receptor agonist Apr 18, 2024
Brenzavvy vs Farxiga for T2D; PFAS in Seafood; 100 Deaths Linked to GLP-1 Drugs? News and commentary from the endocrinology world Apr 16, 2024
No Link Between GLP-1 Drugs and Suicide, Says European Regulator EMA announcement comes a few months after FDA's preliminary evaluation Apr 12, 2024
Surgery May Be More Cost-Effective Than Wegovy in Adults With a BMI 35+ Annual price of semaglutide would have to drop significantly to be comparable Apr 12, 2024
Study Assuages Thyroid Cancer Fears With GLP-1 Receptor Agonists Study findings support conclusions of the European Medicines Agency's recent investigation Apr 10, 2024
Type D Personality and Hypothyroidism; Infertility and eGFR; Fracture Algorithm News and commentary from the endocrinology world Apr 09, 2024
Doc Flung From Trailer Dies; Viral Hepatitis Deaths Rise; Suicidal Thoughts and GLPs Health news and commentary from around the Web gathered by 鶹ý staff Apr 09, 2024
Medicare Can Cover Anti-Obesity Drugs for Heart Disease -- But at What Cost? Intense demand coupled with high costs may place pressures on CMS for years to come Apr 08, 2024
Wegovy Helps HFpEF Patients With Diabetes Mellitus Weight and symptoms improved in STEP-HFpEF DM trial Apr 07, 2024
Weight-Loss Drug Zepbound Faces Supply Issues Following weight-loss indication, patients struggle to obtain tirzepatide Apr 02, 2024
Diabetes Drugs Overpriced; Hormone Drugs and Brain Tumors; Menopause or Herpes? News and commentary from the endocrinology world Apr 02, 2024
Man With Chainsaw Assaults Hospital Staff; Havana Syndrome Case; Ozempic at Costco Health news and commentary from around the Web gathered by 鶹ý staff Apr 02, 2024
GLP-1 Users May Have Increased Endoscopy-Related Aspiration Pneumonia Risk Overall incidence is still low, however Apr 01, 2024
Need 10,000 Daily Steps to Prevent Obesity? It May Depend on Genetics Current recommendations may underestimate activity needs for people with high genetic risk Mar 27, 2024
Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It? News and commentary from the endocrinology world Mar 26, 2024
Medicare to Cover Weight-Loss Drug Wegovy for Certain Patients News comes in the wake of FDA approval to reduce risk of heart attacks, stroke Mar 21, 2024
Automated Insulin System OK'd; Zepbound Gains in Popularity; Male Menopause Cures? News and commentary from the endocrinology world Mar 19, 2024
FDA Approves First-Ever Drug for Serious Liver Condition Resmetirom indicated for NASH patients with liver scarring Mar 14, 2024
Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes News and commentary from the endocrinology world Mar 12, 2024
Online Obesity Program Helped Primary Care Patients Lose Weight Weight regain was less in the groups who participated in 9 months of active maintenance Mar 11, 2024
Deaths Due to Alcohol Use; Steps for the Sedentary Also in TTHealthWatch: microplastics in arteries, and worldwide obesity and diabetes risk Mar 09, 2024 podcast
Cardiometabolic Disorders Tend to Accompany a 'Lazy Eye' Persistent amblyopia associated with myocardial infarction and death Mar 08, 2024
Wegovy Approved for Major Heart Disease Prevention New indication for patients with obesity or overweight and a history of cardiovascular disease Mar 08, 2024
Obesity Drugs Like Wegovy Are Meant for Long-Term Use, but Some Want to Stop Other patients have been forced to ration or halt doses due to drug costs Mar 08, 2024
One-Week GLP-1 Agonist Hold Not Enough Before Anesthesia? Even following this rule, increased residual gastric content still prevalent Mar 07, 2024
10,000 Steps Lowers Death Risk; Obesity Drug Beats Wegovy; Lead in Cinnamon Warning Health news and commentary from around the Web gathered by 鶹ý staff Mar 07, 2024
Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D News and commentary from the endocrinology world Mar 05, 2024
Biden's Physical Results; Weight Loss Implant Tested; Richard Lewis Dies Health news and commentary from around the Web gathered by 鶹ý staff Feb 29, 2024
Abdominal Fat and Dementia; Mask Ban Lawsuit Tossed; FDA Rejects Psych Drug Health news and commentary from around the Web gathered by 鶹ý staff Feb 28, 2024
Bariatric Surgery a Long-Term Winner for Type 2 Diabetes Clinical trials show advantages over lifestyle, medication out to 12 years Feb 27, 2024
